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RESEARCH ARTICLE
Molecular Biology and Physiology
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ABSTRACT The Escherichia coli microcin C (McC) and related compounds are
potent Trojan horse peptide-nucleotide antibiotics. The peptide part facilitates
transport into sensitive cells. Inside the cell, the peptide part is degraded by
nonspeciﬁc peptidases releasing an aspartamide-adenylate containing a phosphoramide bond. This nonhydrolyzable compound inhibits aspartyl-tRNA synthetase. In addition to the efﬁcient export of McC outside the producing cells, special mechanisms have evolved to avoid self-toxicity caused by the degradation of
the peptide part inside the producers. Here, we report that histidine-triad (HIT)
hydrolases encoded in biosynthetic clusters of some McC homologs or by standalone genes confer resistance to McC-like compounds by hydrolyzing the phosphoramide bond in toxic aspartamide-adenosine, rendering them inactive.
IMPORTANCE Uncovering the mechanisms of resistance is a required step for coun-

tering the looming antibiotic resistance crisis. In this communication, we show how
universally conserved histidine-triad hydrolases provide resistance to microcin C, a
potent inhibitor of bacterial protein synthesis.
KEYWORDS HinT, RiPPs, antibiotics, histidine-triad proteins, microcin C, peptide-

nucleotides
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M

icrocin C (McC) is a ribosomally synthesized posttranslationally modiﬁed peptide
(RiPP) antibiotic produced by some strains of Escherichia coli. Homologous compounds are encoded by gene clusters in numerous Gram-negative and Gram-positive
bacteria (1). McC is produced by E. coli cells harboring a conjugative plasmid containing
the mccABCDEF cluster (2). The mccA gene encodes a seven-amino-acid precursor
peptide whose C-terminal residue is modiﬁed by the product of the mccB gene to yield
a peptidyl-adenylate McC1120, in which the C-terminal aspartamide is linked to AMP
through a nonhydrolyzable N-acyl phosphoramidate linkage (Fig. 1) (3). McC1120 is
further modiﬁed by MccD and the N-terminal domain of MccE protein, whose joint
action results in a fully matured microcin C, McC1177, harboring an aminopropyl
decoration on the phosphate moiety (Fig. 1) (4). Both forms of McC are exported from
the producing cell by a specialized transporter encoded by the mccC gene (5).
McC acts through a Trojan horse mechanism. The peptide part facilitates uptake into
the susceptible cell; once inside the cell, the peptide part is proteolytically degraded by
aminopeptidases, releasing toxic “processed McC,” a nonhydrolyzable aspartamideMarch/April 2020 Volume 11 Issue 2 e00497-20
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FIG 1 Structures of nonaminopropylated (McC1120) and aminopropylated (McC1177) E. coli microcin C, processed
forms (McC462 and McC519, respectively), and Asp-AMP, an intermediate of AspRS-catalyzed reaction. The aminopropyl group is indicated by an arrow.
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adenylate (Fig. 1), a structural mimic of intermediate of the reaction of aminoacylation
of tRNAAsp catalyzed by aspartyl-tRNA synthetase (AspRS) (6, 7). Processed McC competitively inhibits AspRS, bringing protein biosynthesis to a halt (5).
Although most McC is efﬁciently exported outside the producing cell by the MccC
pump, intracellular processing by aminopeptidases should inevitably lead to the accumulation of toxic nonhydrolyzable aspartamide-adenylate and self-intoxication of the
producer, since MccC does not export processed McC. Many mcc-like clusters acquired
additional genes whose products help avoid self-intoxication. In the case of E. coli, the
C-terminal domain of MccE, a Gcn5-related N-acetyltransferase (GNAT)-type acetyltransferase, acetylates the ␣-amino group of processed McC, making it unable to bind to
AspRS (8). In addition, MccF peptidase cleaves the carboxamide bond between the
C-terminal aspartamide and AMP of both intact and processed McC (9).
In this work, we report a novel pathway of McC inactivation by histidine-triad (HIT)
superfamily hydrolases encoded in some mcc-like biosynthetic clusters or by standalone genes located elsewhere in bacterial genomes. Proteins of the HIT superfamily
form two separate functional groups: the ﬁrst group includes nucleotide hydrolases,
represented by HinT (10–13), Fhit (13), APTX (14), and Dcsp (15) enzymes, while the
other group includes nucleotide transferases such as GalT (16). The most common
members of the HIT superfamily, HinT proteins, were shown to possess phosphoramidase activity (17). We show that bacterial MccH, a product of a gene in an mcc-like
cluster from Hyalangium minutum, as well as its homologs from Salmonella enterica,
Nocardiopsis kunsanensis, and Pseudomonas ﬂuorescens, are phosphoramidases that
confer resistance to McC-like compounds by hydrolyzing the toxic aspartamideadenylate that is produced after intracellular processing of peptidyl-nucleotides.
RESULTS
Bioinformatic prediction and experimental validation of an unusual mcc operon of
Hyalangium minutum. Bioinformatics analysis reveals a uniquely organized cluster in
the genome of the Gram-negative bacterium Hyalangium minutum DSM 14724 that
may determine the production of two putative McC-like compounds. The cluster
contains two genes coding for putative precursor peptides, MccA1 and MccA2, two
mccB genes, encoding THIF-like adenylyl transferases, and three genes whose products
likely constitute a complex ABC-type transporter with integrated HlyD-like translocator
and C39-like peptidase (18) (Fig. 2A). An additional gene, mccH, is located downstream
of the mccB1 gene and encodes a protein belonging to a histidine-triad (HIT) superfamily (12).
To validate the predicted H. minutum mcc-like cluster, in vitro adenylation reactions
of synthetic MccA1 and MccA2 peptides with recombinant MccB1 and MccB2 adenylyltransferases were performed and products analyzed by matrix-assisted laser desorption
ionization–time of ﬂight mass spectrometry (MALDI-TOF MS). As can be seen from
Fig. 2B and C, incubation of the 36-amino-acid-long MccA1 (MH⫹ at m/z 3,926.2) but
not the 46-amino-acid-long MccA2 (MH⫹ at m/z 4,767.6) with MccB1 and an equimolar
mixture of four nucleotide triphosphates led to the appearance of a mass ion at m/z
March/April 2020 Volume 11 Issue 2 e00497-20
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FIG 2 The mcc-like operon of H. minutum DSM 14724 and its products. (A) Organization of the mcc-like gene
cluster from H. minutum DSM 14724. Genes are represented by colored arrows, with functional predictions
corresponding to each color shown in the key beneath. (B) The mechanism of MccB-mediated adenylation of an
MccA precursor peptide (3). (C) MALDI-TOF MS spectra of products of in vitro reactions between chemically
synthesized H. minutum MccA1 and MccA2 precursor peptides and recombinant MccB1Hmi and MccB2Hmi enzymes
in the presence of ATP. Spectra shown at the top are controls (no MccB enzyme added). The mass difference of
329 Da between MccA1 (m/z 3,926.2) and MccA2 (m/z 4,767.6) mass ions and the mass ions of the reaction products
(m/z 4,255.2 and m/z 5,096.6, correspondingly) matches the modiﬁcation with AMP; the MH⫹ ion at m/z 4,749.6
present in reaction mixtures containing MccA2Hmi and MccB2Hmi is a succinimide intermediate of the nucleotidyl
transfer reaction.

4,255.2. The 329-Da mass increase corresponds to the adenylated form of the peptide.
Conversely, in the presence of MccB2, a prominent MH⫹ ion at m/z 5,096.6 was
observed in reaction mixtures containing MccA2, corresponding to its adenylated form.
An MH⫹ ion at m/z 4,749.6 with 18 mass units less than the original MccA2 ion was also
detected. It corresponds to an MccB-catalyzed adenylation reaction intermediate, a
succinimide derivative of the MccA2 peptide. MccA1 was not modiﬁed by MccB2. We
conclude that the H. minutum mcc-like cluster directs the synthesis of two peptidyladenylates, each synthesized from separate precursors by dedicated MccB enzymes.
We next attempted to reconstruct the production of each of the H. minutum
McC-like compounds in a heterologous E. coli host. Cognate mccA-mccB pairs were
cloned on one expression plasmid, and the mccP1P2P3 genes encoding the putative
transporter were cloned on a compatible plasmid. Under conditions of induction of
plasmid-borne genes, E. coli cells or cellular extracts harboring both plasmid pairs did
not inhibit the growth of an McC-sensitive E. coli tester strain, and no mass ions
corresponding to H. minutum McC-like compounds were detected in cultured medium
(see Fig. S1A in the supplemental material). To test if peptidyl-adenylates are syntheMarch/April 2020 Volume 11 Issue 2 e00497-20

mbio.asm.org 3

Yagmurov et al.

®

Downloaded from http://mbio.asm.org/ on March 11, 2021 by guest

FIG 3 Overproduction of MccHHmi makes E. coli resistant to McC1120 but not to mature E. coli microcin C McC1177. Three
microliters of 5 M solutions of McC1177, McC1120, or 0.5 g/ml gentamicin used as a control was deposited on lawns of E.
coli cells harboring indicated plasmids. The results of overnight growth at 37°C under conditions of the induction of
plasmid-borne genes are shown.

sized but fail to export from the heterologous host, induced cells were subjected to
MALDI-TOF MS. MH⫹ ions at m/z 4,255.2 and 5,096.6 corresponding to full-length
adenylated MccA1 and MccA2, respectively, were identiﬁed in cells harboring plasmids
producing MccA1-MccB1 and MccA2-MccB2 pairs. In addition, MH⫹ ions at m/z 4,124.2
and 4,965.6, corresponding to adenylated MccA1 and MccA2 peptides lacking the ﬁrst
methionine residue, were detected. Unmodiﬁed full-sized MccA1 and MccA2 polypeptides (MH⫹ ions at m/z 3,926.2 and 4,767.6, respectively) and their derivatives lacking
methionine (MH⫹ ions at m/z 3,795.2 and 4,636.6) were also observed (Fig. S1B). Thus,
two distinct products of the H. minutum mcc cluster are produced in the heterologous
host but fail to be exported at a detectable level.
MccHHmi confers McC immunity when overproduced in E. coli. We hypothesized
that MccHHmi is a HIT superfamily phosphoramidase that provides H. minutum with
self-immunity through the inactivation of McC-like compounds. To check this conjecture, we cloned the mccHHmi gene in an arabinose-inducible E. coli expression vector.
We also created plasmids overproducing HinTHmi, a product of a standalone H. minutum gene, and its E. coli homologue HinTEco. Since the ﬁnal toxic aspartate-adenylate
forms of McC produced by H. minutum and E. coli should be identical (Fig. 1, McC462),
we tested the susceptibility of MccH- or HinT-expressing cells to E. coli McC1120.
Additionally, we used the aminopropylated form of E. coli McC, McC1177. In the assay,
the drops of solutions of two active forms of E. coli McC were deposited on lawns of E.
coli B McC-sensitive cells producing HIT proteins or harboring control empty vector
(Fig. 3). The results revealed that the size of the growth inhibition zones around drops
of fully mature McC1177 solution on lawns of HIT protein-producing cells was the same
as that on the control cell lawn. In contrast, E. coli cells overexpressing the mccHHmi
gene were completely resistant to McC1120, an intermediate of the E. coli McC maturation process that does not contain the aminopropyl moiety. The expression of either
hinTEco or hinTHmi had no effect on the size of growth inhibition zones produced by
McC1120 (Fig. 3). All HIT proteins were produced in comparable amounts, as judged by
SDS-PAGE (Fig. S2). We therefore conclude that the MccHHmi but not HinT proteins
tested can provide resistance to externally added toxic peptidyl-adenylate.
MccHHmi hydrolyzes the phosphoramide bond connecting the aminoacyl and
nucleotide moieties of processed McC1120. To determine the mechanism of
MccHHmi-mediated resistance to toxic peptidyl-nucleotide, recombinant MccHHmi,
HinTHmi, and HinTEco were puriﬁed and incubated with unprocessed McC1120 or
McC1177, and the reaction products were analyzed by reverse-phase high-performance
liquid chromatography (RP-HPLC) and MALDI-TOF MS. No changes were observed after
a 1-h incubation (data not shown). Since no hydrolytic activity against either form of E.
coli McC was detected, we considered whether the processed forms of McC1120 and
McC1177 could be the substrates of MccHHmi. To this end, aspartamide-adenylates with
(McC519) and without (McC462) the aminopropyl group were prepared by in vitro
processing of McC1177 and McC1120 (see Materials and Methods). After incubation with
March/April 2020 Volume 11 Issue 2 e00497-20
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FIG 4 MccHHmi hydrolyzes aspartamide-adenylate McC462. (A) RP HPLC elution proﬁles of the products of
incubation of aspartamide-adenylate McC462 with MccHHmi, HinTHmi, and HinTEco. (B) MALDI-TOF MS and MS-MS
fragmentation analyses of McC462 and the product of its hydrolysis by MccHHmi. For a description of the mass ions,
refer to the text. (C) Scheme of an aspartamide-adenylate hydrolysis reaction by MccHHmi.

MccHHmi, HinTHmi, or HinTEco, samples were analyzed by RP-HPLC and MALDI-TOF MS.
Since the expected phosphoramidase activity of MccHHmi should result in the appearance of AMP or adenosine 5=-phosphoramidate, we used AMP as a marker (Fig. 4A).
Upon a 1-h incubation with MccHHmi, McC462 was completely converted into a new
compound with the same chromatographic mobility as AMP (Fig. 4A). The MH⫹ ion of
this compound had m/z 348.1, matching that of AMP (Fig. 4B). The MS-MS fragmentation spectra conﬁrmed this assignment (Fig. 4B). None of the enzymes was able to
hydrolyze fully processed microcin with aminopropyl decoration (McC519) (Fig. S3).
In the presence of HinTEco or HinTHmi, McC462 remained largely intact, with only
trace amounts of AMP formed in the course of the reaction. We therefore decided to
assess whether HinTHmi is an active phosphoramidase using AMP-N--(N-␣-acetyl-lysine
methyl ester)-5=-phosphoramidate (K-AMP), a previously described HinT phosphoramidase model substrate (17). Incubation of K-AMP with HinTHmi, HinTEco, or MccHHmi,
followed by RP-HPLC and MALDI-TOF MS, revealed that both HinTHmi and HinTEco
hydrolyzed it with the release of AMP, while MccHHmi did not (Fig. 5A to C). We
therefore conclude that the MccHHmi hydrolase cleaves the P-N bond in aspartamideadenylate but not in K-AMP. HinTHmi and HinTEco have different speciﬁcities, where
they hydrolyze K-AMP well but are largely inactive toward processed McC1120 (Fig. 4A
and 5A). These results explain why both HinT enzymes failed to provide resistance to
McC in the antibiotic susceptibility test under our conditions in vivo (Fig. 3).
MccH homologs are present in diverse bacteria. HIT domain-containing proteins
are widespread among prokaryotes (see Materials and Methods for details on domain
identiﬁcation). A phylogenetic tree constructed using available HIT domain sequences
revealed that MccHHmi belongs to a distinct clade, highlighted in red in Fig. 6A (see also
Fig. S4). This clade also contains proteins from putative mcc-like clusters from Nocardiopsis, Pseudomonas, and Thermobiﬁda spp., as well as multiple proteins encoded by
standalone genes. Genes encoding MccH homologs from the mcc-like cluster from
Nocardiopsis kunsanensis DSM 44524, as well as standalone genes from Pseudomonas
March/April 2020 Volume 11 Issue 2 e00497-20
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FIG 5 Substrate speciﬁcity of MccHHmi, HinTHmi, and HinTEco phosphoramidases. (A) HPLC elution proﬁles of
products of incubation of K-AMP with HinTEco, HinTHmi, or MccHHmi. (B) MALDI-TOF MS analysis of the hydrolysis
reaction of the K-AMP by HinTHmi protein. (C) Scheme of a HinT-mediated hydrolysis reaction of K-AMP (36).

ﬂuorescens A506, Salmonella enterica serovar Newport, Microcystis aeruginosa PCC9809,
and Parcubacteria sp. strains GWA24037 and DG742, were cloned into an E. coli
expression vector, and the ability of the resulting plasmids to make E. coli cells resistant
to the two forms of McC was tested. As can be seen from Fig. 6B, overexpression of
most MccH-like genes led to resistance to McC1120 but not to McC1177. The apparently
inactive MccH-like proteins from M. aeruginosa strain PCC9809 and Parcubacteria sp.
strain DG742 are the earliest branching MccH homologs tested, and they may have
evolved different substrate speciﬁcities.
Mutational analysis of MccH active center. The mechanism of nucleotide phosphoramidate hydrolysis is best studied for the E. coli enzyme, HinTEco (19), and its
human homologue, hHint1 (20, 21). The characteristic feature of the HIT superfamily
proteins is a conserved histidine-triad motif, HxHxHxx, where H is a histidine, and x is
a hydrophobic residue (12). The three essential catalytic histidines form a network of
hydrogen bonds with the substrate that promotes proton transfer from the protonated
C-terminal histidine of the triad (H103 in HinTEco or H102 in HinTHmi) to phosphoramidate unbridged oxygens and amide nitrogen and facilitate nucleophilic attack of the
central histidine (HinTEco H101 or HinTHmi H100) on the phosphorus atom, resulting in
P-N bond hydrolysis (19, 21, 22). Another conserved His residue, H39 in HinTEco (H38 in
HinTHmi), located outside the triad motif closer to the N terminus of HIT enzymes,
contributes to catalysis by stimulating the protonation of the third histidine of the triad
by stabilizing its cationic state (21). Mutational analysis of human Hint1, a close
homologue of HintEco, revealed that substitutions of conserved histidines equivalent to
H39 and H103 in HinTEco substantially reduce the catalytic activity (22).
Interestingly, HIT proteins of the MccH clade contain a modiﬁed motif where the
third histidine is substituted for lysine (K103 in MccHHmi). Together with this substituMarch/April 2020 Volume 11 Issue 2 e00497-20
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FIG 6 Diversity of McC-speciﬁc phosphoramidases. (A) Approximate maximum likelihood (ML) phylogenetic tree of the HIT
domain proteins from completely sequenced genomes. Dark magenta and dark red indicate HinT-like proteins (dark red
shows the protein kinase C interacting protein-related subgroup), bright red indicates the MccHHmi clade that is expanded
in panel B, cyan indicates GalT, and green indicates FHIT. In black are clades without any clear proﬁle signature. The arrows
point to HinTEco (within the PKCI clade) and MccHHmi. (B) Approximate ML phylogenetic tree of proteins within the MccHHmi
clade and growth inhibition zones formed by McC1120 and McC1177 on lawns of E. coli B cells transformed with plasmids
expressing MccHHmi or homologs from the indicated positions on the tree. The MccHHmi branch is highlighted in red. sv.,
serovar.

tion, MccH-like proteins lost the N-terminal conserved histidine (H39 in HintEco), which
is replaced by phenylalanine (F44 in MccHHmi) (Fig. 7A and S4). Structural modeling (see
below) indicates that F44 makes hydrophobic contacts with the side chain of K103 in
MccHHmi (Fig. 8A). In addition, all members of MccH clade acquired glutamate (E93 in
MccHHmi) ﬁve residues away from the triad motif. In the structural model of MccHHmi,
E93 makes a hydrogen bond (or a salt bridge) with K103, thus playing the same
functional role as H39 in HinTEco (H38 in HinTHmi) (Fig. 8). Since this triple substitution
should still allow phosphoramide bond hydrolysis, we speculate that the positively
charged lysine occupying position of H103 in MccHHmi ultimately donates its stationary
proton to the nitrogen of the phosphoramide bond (Fig. 8B). To test this conjecture and
better understand the origin of MccH-like protein speciﬁcity, we prepared two MccHHmi
mutants harboring the single substitutions K103H and F44H. An MccHHmi K103H-F44H
double mutant was also engineered. As a key residue in the triad, H101 in MccHHmi is
supposed to directly participate in catalysis. Therefore, a protein with substitution
H101N was prepared and tested for phosphoramidase activity. As expected, the H101N
mutant, which served as a control, was catalytically inactive, i.e., no hydrolysis of
processed McC1120 was detected (Fig. 7B). The K103H substitution had also eliminated
March/April 2020 Volume 11 Issue 2 e00497-20
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FIG 7 Mutational analysis of active site residues of MccHHmi. (A) Sequence alignment of the conserved
HIT motif of HinTEco and MccHHmi. (B) Phosphoramidase activity of MccHHmi active-site mutants. In vitro
reaction mixtures containing aspartamide-adenylate McC462 were incubated with wild-type MccHHmi and
the mutant proteins, containing the H101N or K103N substitution, and then analyzed by RP-HPLC. The
conversion of McC462 was calculated as the percentage of McC462 and AMP absorption peak areas that
remained after the reaction completion relative to the corresponding peak areas observed without the
addition of enzymes. The bars represent the mean ⫾ standard deviation (SD) conversion percentages
calculated from three independent measurements. (C) Mutations in the active center of MccHHmi abolish
immunity to McC1120. Growth inhibition of E. coli cells harboring pBAD plasmids encoding the indicated
proteins. Solutions (5 M) of McC1120 and 0.5 g/ml gentamicin were deposited on freshly prepared
lawns and allowed to grow overnight at 37°C under conditions of induction of plasmid-borne genes.

the hydrolytic activity of MccHHmi, conﬁrming that a lysine characteristic of MccH-like
proteins is essential for the catalytic function. The F44H mutant retained its activity,
which is also an expected result. The K103H-F44H double mutant was insoluble, and
thus, its enzymatic properties could not be assessed. To conﬁrm the in vitro hydrolytic
activity of the mutants, the E. coli cells harboring the corresponding plasmids were
tested for their susceptibility to McC1120. As shown in Fig. 7C, the H101N and K103H
substitutions completely abolished immunity to peptidyl-adenylates, while the phenotype of MccHHmi F44H-expressing cells was indistinguishable from that of the cells
producing wild-type MccHHmi.

FIG 8 Three-dimensional structural model of MccHHmi and proposed catalytic mechanism. (A) Model structure of MccHHmi
generated by the SWISS-MODEL homology modeling server (23) using as the template the crystal structures of the HIT-like
protein from Mycobacterium paratuberculosis (PDB 3P0T) (24) and human HINT1-AMP complex (PDB 3TW2) (28). Positions
of catalytic residues in the MccHHmi active site in complex with AMP are shown as atom type-colored sticks: N, blue; O, red;
P, orange. The C atoms in AMP are in yellow, and the C atoms in the side chains are in light green. (B) Schematic diagram
representing the active site of MccHHmi with the bound substrate, aspartamide-adenylate (the aspartyl moiety is represented by R and shown in blue). Residues of the ExxxxxHxHxKxx motif conserved among all members of the MccH clade
that are directly involved in the catalysis are shown in red. Potential hydrogen bonds between peptide side chains,
backbone atoms, and phosphate oxygens are indicated by dashed lines. The proton to be transferred from the -amino
group of K103 to the unbridged oxygen of the phosphoramide is depicted in dark red. Nucleophilic attack of the
unprotonated nitrogen of H101 on electrophilic phosphorus atom is shown by a curved arrow.
March/April 2020 Volume 11 Issue 2 e00497-20
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Structural model of MccHHmi. The loss of functional activity by MccHHmi mutant
K103H suggested that this residue, which is speciﬁc to MccH clade proteins, is involved
in substrate binding and/or catalysis. We also hypothesized that some other active-site
residues might spatially constrain the catalytic pocket environment favoring the ﬂexible
aliphatic side chain of lysine over a more rigid imidazole ring of histidine. To explore the
possible spatial organization of the active center of MccHHmi, we generated its threedimensional (3D) model using the SWISS-MODEL homology modeling program (23).
The resulting model of MccHHmi (Fig. 8A) is based on a top-ranked Mycobacterium
paratuberculosis HIT-like protein structure (PDB 3P0T) (24) with a global model quality
estimate (GMQE) quality score of 0.68, indicative of good reliability and accuracy. To
reveal the potential interactions in the substrate-binding pocket, the model structure of
MccHHmi was superimposed with the crystal structure of the human histidine-triad
nucleotide-binding protein 1 (hHINT1) in complex with AMP (PDB 3TW2) (25).
As expected, the overall structure of MccHHmi and the spatial organization of its
active site are very similar to those of other HinT and HIT-like proteins, with a notable
exception of the C-terminal nonconserved 45 amino acids that model differently
depending on the homology template used. In the model, MccHHmi forms a symmetric
homodimer with each protein monomer capable of binding and hydrolyzing the
substrate (Fig. S5). The nucleoside-binding pocket is formed mostly by conserved
hydrophobic residues F11, F12, L15, F34, P37, V46, F38, and I97. The hydroxyl group of
T36 makes a hydrogen bond with ribose 2=-OH in AMP, thus contributing to nucleotide
recognition. The N atoms of the side chains of catalytic H101 and K103 are positioned
(2.5 to 2.7 Å) to make strong hydrogen bonds with the P and unbridged O atoms of the
phosphate moiety of AMP, respectively (Fig. 8A). The interatomic distances (2.9 to 3.6 Å)
between the peptide backbone amide and carbonyl groups of residues G96, I97, and
H99 and their interacting partners (unbridged oxygen and the protonated N atom
of H101, respectively) are within a range that is optimal for hydrogen bonding and
consistent with the proposed catalytic mechanism (Fig. 8B). Unexpectedly, the carbonyl
group of E93, a conserved residue among members of the MccH clade, is in close
proximity (2.3 Å) to the protonated N atom of K103, suggesting a strong hydrogen
bond or salt bridge that would stabilize the charged state of K103 and facilitate the
catalysis. Furthermore, consistent with the results of our mutagenesis experiments
(Fig. 7), the bulky hydrophobic side chains of F44 and F91 replacing conserved H39 and
I86 in HinTEco and HinTHmi, about the side chain of K103, stabilize its conformation and
direct it toward the phosphate. Thus, the positioning of F44, F91, and E93 in the active
center explains the observed preference for a catalytic lysine in MccH instead of
histidine in the HinT clade.
DISCUSSION
In this work, we uncover a novel mechanism of immunity to microcin C-like
compounds by MccHHmi, a HIT-like phosphoramidase encoded in the mcc cluster of H.
minutum. The cluster produces two separate peptide-adenylates that are analogous to
McC1120, a toxic maturation intermediate of E. coli McC that lacks the aminopropyl
decoration. As of today, the mcc operon from H. minutum is the only validated operon
that produces two McC-like compounds with different peptide parts. Since peptide
parts determine the speciﬁcity of antibacterial action by allowing selective import into
sensitive cells (26), H. minutum DSM 14724 may target distinct, nonoverlapping sets of
its competitors by the McC-like compounds it produces.
Like other McC-producing organisms, H. minutum should experience the buildup of
toxic processed products inside the cell, which could lead to the cessation of protein
biosynthesis. The MccHHmi enzyme, the product of the mcc operon, alleviates this
problem by cleaving the bond between phosphorus and nitrogen in the toxic
aspartamide-adenylate that is produced after proteolytic processing of either of the
two McC-like compounds encoded by the operon, thus providing self-immunity to the
producing cell. MccHHmi makes cells resistant to the maturation intermediate of E. coli
McC that lacks the aminopropyl decoration but not to fully mature McC1177. The
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catalytic mechanism of phosphoramide hydrolysis requires a transient protonation of
two unbridged oxygens (21, 22). The presence of an additional aminopropyl group
on the phosphate in unprocessed McC1177 and processed McC519 precludes the
proton transfer reaction and renders the phosphorus center inaccessible to nucleophilic attack by the catalytic histidine (HinTEco H101, HinTHmi H100, or MccHHmi
H101). Thus, H. minutum and E. coli mcc operons use different strategies to
overcome the self-intoxication of producers. The H. minutum mcc operon produces
two peptidyl-adenylates without additional modiﬁcations, and the processing of
both compounds leads to identical toxic aspartamide-adenylate. MccHHmi hydrolyzes the phosphoramide bond in aspartamide-adenylate with the formation of
AMP and aspartamide. The absence of additional genes in the H. minutum mcc
operon that may be involved in self-immunity suggests that MccHHmi is sufﬁcient to
counter the inhibitory effects caused by the buildup of the toxic product. In E. coli,
the MccD/E enzyme complex installs the aminopropyl decoration at the phosphate
of peptide-adenylate, which allows the potency of antibacterial action to be
increased ⬃10-fold by increasing the afﬁnity of the processed compound to its
target, AspRS (4). The presence of activity-enhancing decoration renders the
MccHHmi enzyme inactive, necessitating another mechanism to overcome selfintoxication. MccE detoxiﬁes both aminopropylated and nonaminopropylated
aspartamide-adenylates by acetylating the amino group of the aspartate (8).
The structural model of MccHHmi built based on a crystal structure of homologous
HIT-like protein from M. paratuberculosis (PDB 3P0T) (24) provides a plausible view on
a spatial organization of the active center and offers clues to understanding the
enzyme’s substrate speciﬁcity. Importantly, the model points to the functional role of
the conserved hydrophobic (F44 and F91) and charged (E93) residues in the activation
of catalytic K103 for the hydrolysis of aspartamide-adenylate that can be tested
experimentally. It is also predicted that residues M95 and W115 of the C-terminal loop
of one MccH monomer together with L110 from the adjacent C-terminal loop of the
other MccH monomer form a tight aspartamide-binding site which would sterically
occlude the binding of bulkier groups, such as the -lysine amide of K-AMP. This view
is consistent with the fact that HinTEco lacking the C-terminal extension present in
MccHHmi was active toward K-AMP but could not hydrolyze aspartamide-adenylate. It
is also supported by previous observations that both deletion and swapping of the
C-terminal loop between human HINT1 and HinTEco strongly affect both the catalytic
activity and substrate speciﬁcity (19, 27, 28). The proposed model will be validated in
our future genetic, biochemical, and structural studies of bacterial MccH and HinT
proteins.
Previous studies have shown that bacterial and human HinT proteins exhibit a broad
substrate speciﬁcity; they can accommodate both purine and pyrimidine nucleotides
with various substitutions in the aminoacyl moiety, including D- and L-stereoisomers of
tryptophan and sterically hindering N--(N-␣-acetyl-lysine methyl ester)-adenosine
phosphoramidates (11, 27). Unlike HinT, the MccHHmi and its homologues from four
diverse bacterial species characterized in this work apparently have evolved much more
specialized enzymes that show a clear preference for aspartamide-adenylate (Fig. 4 and
5). Our results suggest that the fully processed McC is a bona ﬁde substrate for MccH. We
speculate that MccH-like proteins from M. aeruginosa PCC9809 and Parcubacteria sp.
DG742, which are inactive toward E. coli McC, may recognize yet-unidentiﬁed speciesspeciﬁc McC-like compounds that carry different nucleoside or amino acid moieties.
MATERIALS AND METHODS
Molecular cloning. E. coli DH5␣ was used for cloning. All primers were synthesized by Evrogen
(Russia); their sequences are listed in Table S1. The H. minutum DSM 14724 or E. coli BW25113 genomic
DNA was used as the template for PCR. Phusion DNA polymerase (Thermo Scientiﬁc) was used for PCR.
For MccB1Hmi and MccB2Hmi activity analysis, their coding sequences were ampliﬁed from the H.
minutum DSM 14724 genomic DNA. The PCR products were digested with BamHI and SalI restriction
endonucleases and inserted under the same sites into the pET22_MBP vector (26) to create an N-terminal
fusion protein with a maltose-binding protein (MBP) tag.
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For the heterologous mccHmi expression system, a DNA fragment spanning the mccP1Hmi, mccP2Hmi,
and mccP3Hmi genes was ampliﬁed from genomic DNA, digested with EcoRI and KpnI, and inserted into
pACYCDuet-1 vector (Novagen-Millipore, USA) linearized with the same restriction endonucleases. To
construct MccA-MccB expression vectors, ﬁrst, the phosphorylated self-complementary oligonucleotides
containing sequences of the MccA1Hmi and MccA2Hmi open reading frames (ORFs) were inserted into the
pRSFDuet-1 vector (Novagen-Millipore, USA) and digested with NcoI and HindIII, resulting in the
pRSF-MccA1Hmi and pRSF-MccA2Hmi vectors, respectively. Then, mccB1Hmi and mccB2Hmi were PCR ampliﬁed, digested with NdeI and KpnI, and inserted into the pRSF_mccA1Hmi and pRSF_mccA2Hmi vectors
linearized with NdeI and KpnI, resulting in pRSF_mccA1B1Hmi and pRSF_mccA2B2Hmi, respectively.
To obtain an arabinose-inducible vector for the heterologous expression of HIT proteins, the
pBAD/His B vector (Invitrogen-Thermo Fisher, USA) was linearized by PCR with the appropriate primers
that contained an introduced ribosomal binding site and SalI and HindIII restriction sites to generate
pBAD30_SalRBS. Next, the mccHHmi, hinTHmi, and hinTEco genes were PCR ampliﬁed using genomic DNA
as the template and the corresponding primers. Genes encoding the homologs of MccHHmi were
purchased as synthetic DNA fragments from IDT, USA. All ampliﬁed PCR products and synthetic
fragments were digested with SalI and HindIII and inserted between the same sites into the pBAD30
expression vector.
To create vectors for HIT protein fused with C-terminal His6 tags for protein puriﬁcation, the mccHHmi,
hinTHmi, and hinTEco genes were PCR ampliﬁed, digested with NdeI and XhoI, and inserted into the
pET22(b) vector (Novagen-Millipore, USA). The site-directed mutagenesis of mccHHmi was carried out
using overlap extension PCR (29), with appropriate primers.
Recombinant protein expression and puriﬁcation. Recombinant proteins were produced in E. coli
BL21(DE3) transformed with the appropriate plasmid. The cells were grown in 500 ml of TB medium
supplemented with ampicillin to an optical density at 600 nm (OD600) of ⬃0.7 and induced with 0.2 mM
isopropyl-␤-D-thiogalactopyranoside (IPTG). After induction, the culture was transferred for overnight
growth at 18°C and 180 rpm. The cells were harvested by centrifugation at 8,000 ⫻ g and 4°C for 20 min,
resuspended in ice-cold resuspension buffer (20 mM Tris-HCl, 300 mM NaCl, 1 mM dithiothreitol [DTT]
[pH 8.0]), supplemented with 1 mM phenylmethylsulfonyl ﬂuoride (PMSF), and disrupted by sonication.
For the His-tagged proteins, imidazole was added up to 2 mM. The lysate was cleared by centrifugation
at 30,000 ⫻ g and 4°C for 20 min. The cleared lysate was applied to a preequilibrated column with a
tag-binding resin; depending on the tag present, either amylose resin (NEB) or Talon CellThru Co2⫹chelating resin (TaKaRa-Clontech) was used. The resin was washed with 10 column volumes of resuspension buffer, followed by elution with 5 column volumes of the elution buffer (20 mM Tris-HCl [pH 8.0],
50 mM NaCl, 10% glycerol) supplemented with either 10 mM maltose or 0.5 M imidazole.
Adenylation of MccA1Hmi and MccA2Hmi. For validation of the MccA-MccB pairs of the H. minutum
mcc-like gene cluster, in vitro modiﬁcation of synthetic MccA1Hmi (MNDKATIEIKKDEKKAEPKKVVVVKTSIK
AGPAAFN) and MccA2Hmi (MNEKTAQESQKTESPKAETPAKKAVIVKTRIKAGPGGGGLVHPIAN) (GenScript, USA)
peptides using puriﬁed MccB1Hmi and MccB2Hmi reactions was performed. Reaction mixtures contained 50
M synthetic peptides (either MccA1Hmi or MccA2Hmi), 5 M recombinant MccB1Hmi or MccB2Hmi, and 2
mM each nucleoside triphosphate (NTP) in the reaction buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl,
10 mM MgCl2, 5 mM DTT). The reaction was carried out at 30°С for 16 h and then stopped by the addition
of 0.1% triﬂuoroacetic acid (TFA) in water. The products of the reaction were analyzed by MALDI-TOF MS
for the presence of adenylated MccA1Hmi and MccA2Hmi.
McC1Hmi and McC2Hmi production test. E. coli BL21(DE3) cells harboring a combination of either
pRSF_mccA1B1Hmi and pACYC_mccP1P2P3Hmi or pRSF_mccA2B2Hmi and pACYC_mccP1P2P3Hmi plasmids were
grown in 25 ml of 2xYT medium (1.6% Tripton, 1% yeast extract, 0.5% NaCl) at 30°C with constant shaking
at 180 rpm. Upon reaching an OD260 of ⬃0.7, the cells were induced with 0.25 mM IPTG and grown for
an additional 20 h at 30°C. After that, the cells were pelleted at 5,000 ⫻ g and resuspended in 250 l of
M9 medium. Aliquots of 15 l were deposited on a freshly prepared M9 agar lawn of E. coli strain B
harboring the pRSFduet-1, pETduet-1, and pACYCduet-1 vectors. Plates were incubated at 30°C overnight
to allow formation of the lawn. The next day, the plates were inspected for the presence of growth
inhibition zones. Additionally, the cells and the surrounding agar were analyzed for the presence of
McC-like products using mass spectrometry.
In vivo immunity assay. E. coli strain B was transformed with pBAD_SalRBS vectors containing the
mccHHmi gene or its homologues. The overnight cultures of the E. coli cells with the appropriate vectors
were diluted 1,000-fold in M9 agar medium supplemented with 1% glycerol, 0.02% yeast extract, 10 mM
arabinose, and 100 g/ml ampicillin. The sensitivity of cells carrying plasmid-borne genes encoding
HIT-like proteins was measured by applying 5-l drops of 5 M McC1120 and 5 M McC1177 on the surface
of the plate and allowed to dry, and gentamicin (0.5 g/ml) was used as a control growth inhibitor. Plates
were incubated for 16 h at 30°C for a lawn to form. The next day, the growth inhibition zones were
analyzed.
K-AMP synthesis. The synthesis of K-AMP was performed as described elsewhere, with minor
modiﬁcations (17). To synthesize K-AMP, 0.12 g (6.25 mmol) of 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide HCl (Sigma-Aldrich) was added to the ﬂask containing 0.98 g (2.7 mmol) of AMP (SigmaAldrich), 0.1 g of (0.42 mmol) N-␣-acetyl-L-lysine methyl ester HCl (Sigma-Aldrich), and 10 ml of ultrapure
water, and the pH of the solution was adjusted with triethylamine to a value of 7.5. The mixture was
incubated in the shaker at 65°C, with vigorous shaking at 250 rpm for 22 h. After allowing the reaction
mix to cool down to room temperature, the mixture was lyophilized, redissolved in 0.1% TFA in water,
and applied to a Luna 5-m C18 100-Å, LC column (250 by 10 mm; Phenomenex). The puriﬁcation of
K-AMP was performed in a linear gradient (5 to 25%) of acetonitrile. The fractions were analyzed for the
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presence of K-AMP by MALDI-TOF mass spectrometry, and fractions containing K-AMP were subjected
to additional chromatographic puriﬁcation on the same column in a linear gradient of acetonitrile (0 to
25%) in triethylammonium acetate (TEAA) buffer (pH 6.5).
In vitro phosphoramidase activity assay. To test the phosphoramidase activity of MccHHmi, HinTHmi,
HinTEco enzymes, and their respective variants, the processed forms of E. coli McC1177 and McC1120
(McC519 and McC462, respectively) and K-AMP were used as the substrates. For production, puriﬁcation,
and processing of McC forms, refer to the study by Metlitskaya et al. (6). Fifty micromolar processed McC
or K-AMP was mixed with 5 M the enzyme in the reaction buffer (20 mM HEPES [pH 7.2], 2.5 mM MgCl2,
2.5 mM MnCl2). The reaction mixture was incubated at 25°С for 30 min, terminated by the addition of
0.1% TFA, and analyzed for hydrolysis by HPLC and mass spectrometry.
Reverse-phase HPLC analysis of the products of the in vitro reactions. All biochemical reactions
were analyzed on 1220 Inﬁnity II LC system (Agilent), and the peak separation occurred on a Zorbax
Eclipse Plus C18 5-m (4.6 by 250 mm) column (Agilent) in a 0.1 M TEAA buffer system (pH 6.0) in the
varying linear gradient of acetonitrile.
The products of McC462 hydrolysis reactions were separated in a linear gradient of acetonitrile (0 to
20%) over a period of 15 min. After the incubation of McC519 with HIT enzymes, the reaction products
were separated in the acetonitrile gradient (0 to 22%) for 15 min. After hydrolysis of K-AMP by HIT
enzymes, the reaction products were analyzed in the linear acetonitrile gradient (5 to 30%) lasting for 15
min. The chromatograms were processed with the use of the ChemStation software (Agilent), and elution
proﬁles were exported in comma-separated values format.
Mass spectrometry analysis. One to two microliters of the sample aliquots was mixed with 0.5 l
of matrix mix (Sigma-Aldrich) on a steel target. The mass spectra were recorded on an UltraﬂeXtreme
MALDI-TOF/TOF mass spectrometer (Bruker Daltonics) equipped with a neodymium laser. The molecular
MH⫹ ions were measured in reﬂector mode; the accuracy of the measured results was within 0.1 Da.
Sequence analysis. Proteins containing the histidine catalytic triad were identiﬁed in 4,621 completely sequenced genomes available in 2016. Proﬁles belonging to the NCBI CDD (30) superfamily
cl00228 were used as PSI-BLAST (31) queries to search the protein sequences encoded in this set. The
resulting set of 10,580 proteins was clustered using UCLUST (32) and aligned using MUSCLE (33) (Fig. S6);
alignments were iteratively compared to each other using HHSEARCH and aligned using the HHALIGN
program (34). The approximate ML tree was reconstructed using the FastTree program (35) with a WAG
evolutionary model and gamma-distributed site rates.
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